Role of liver transplantation in cancer therapy.

PubWeight™: 4.08‹?› | Rank: Top 1%

🔗 View Article (PMC 1250934)

Published in Ann Surg on October 01, 1985


S Iwatsuki, R D Gordon, B W Shaw, T E Starzl

Articles citing this

Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78

Liver transplantation (1). N Engl J Med (1989) 4.53

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg (1993) 3.91

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg (1988) 3.04

The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg (1989) 2.71

Personal experience with 411 hepatic resections. Ann Surg (1988) 2.46

Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg (2002) 2.14

Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg (1993) 2.06

Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg (1998) 1.90

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg (2004) 1.88

Factors in the Development of Liver Transplantation. Transplant Proc (1985) 1.74

Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer (1991) 1.68

Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation (1988) 1.61

Current treatment modalities for hepatocellular carcinoma. Ann Surg (1994) 1.59

Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients. World J Gastroenterol (2006) 1.58

Postoperative recurrence of hepatocellular carcinoma. Ann Surg (1990) 1.55

Liver transplantation for hepatocellular carcinoma. Ann Surg (2001) 1.46

Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg (1997) 1.36

Liver transplantation in the treatment of primary liver cancer. Hepatogastroenterology (1990) 1.24

Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg (2007) 1.18

Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas. Surg Gynecol Obstet (1989) 1.17

Indications for pediatric liver transplantation. J Pediatr (1987) 1.12

Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis. Ann Surg (1999) 1.09

Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma. HPB (Oxford) (2010) 1.05

Living donor liver transplantation for patients with hepatocellular carcinoma. Liver Cancer (2014) 1.00

Liver transplantation for hepatocellular carcinoma: an appraisal of current controversies. Liver Cancer (2012) 0.99

The changing face of hepatic resection. Curr Probl Surg (1989) 0.96

Late mortality and morbidity after liver transplantation. Transplant Proc (1987) 0.95

Liver transplantation for hepatoblastoma. The American experience. Ann Surg (1991) 0.94

Pathologic analysis of liver transplantation for primary biliary cirrhosis. Hepatology (1988) 0.94

Management of Hepatocellular Carcinoma: Current Status and Future Directions. Gut Liver (2015) 0.92

Current surgical treatment strategies for hepatocellular carcinoma in North America. World J Gastroenterol (2014) 0.90

Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases. Cancer (1991) 0.89

Present position of liver transplantation and its impact on hepatological practice. Gut (1988) 0.89

Androgen receptor in hepatocellular carcinoma as a prognostic factor after hepatic resection. Ann Surg (1989) 0.89

Liver transplantation for hepatocellular carcinoma: clinical results and future aspects. Cancer Chemother Pharmacol (1992) 0.88

Management of hepatocellular carcinoma in Japan. J Gastroenterol (2006) 0.87

Early Hepatocellular Carcinoma: Transplantation versus Resection: The Case for Liver Resection. Int J Hepatol (2011) 0.86

Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology. Gut (1999) 0.85

Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival. J Pediatr Surg (1992) 0.85

Liver disease in a district hospital remote from a transplant centre: a study of admissions and deaths. Gut (1992) 0.85

Progress in liver transplantation. Adv Surg (1988) 0.83

Experience with resection of primary hepatic malignancy. Surg Clin North Am (1989) 0.82

ZIP4, a novel determinant of tumor invasion in hepatocellular carcinoma, contributes to tumor recurrence after liver transplantation. Int J Biol Sci (2014) 0.81

Experience of a Canadian multi-organ transplant service. CMAJ (1986) 0.80

Role of liver transplantation for hepatocellular carcinoma. J Clin Exp Hepatol (2014) 0.80

Experience with transplantation in the treatment of liver cancer. Cancer Chemother Pharmacol (1989) 0.80

Surgical treatment of hepatocellular carcinoma in China: surgical techniques, indications, and outcomes. Langenbecks Arch Surg (2005) 0.80

What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma? Liver Transpl (2011) 0.80

Liver transplantation as a management of hepatocellular carcinoma. World J Hepatol (2015) 0.80

Liver transplantation for hepatocellular carcinoma on cirrhosis: strategies to avoid tumor recurrence. World J Gastroenterol (2011) 0.79

Liver transplantation: current concepts. CMAJ (1988) 0.79

Historical perspective of living donor liver transplantation. World J Gastroenterol (2008) 0.79

The Denver-Pittsburgh liver transplant series. Clin Transpl (1987) 0.79

Liver transplantation and primary biliary cirrhosis. Postgrad Med J (1989) 0.78

Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol (2017) 0.78

Surgical approach for hepatitis C virus-related hepatocellular carcinoma. World J Hepatol (2015) 0.76

Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria. World J Hepatol (2016) 0.75

WHICH LIVER-DESEASE PATIENTS NEED A TRANSPLANT?: Organ replacement has come into its own as a treatment for end-stage liver disease. A team of experts from two leading transplant centers reviews current indications, survival rates, and methods of evaluating candidates for operation. Hosp Rec Study (1988) 0.75

Proceed with caution: liver transplantation for metastatic neuroendocrine tumors. Ann Surg (1997) 0.75

Recurrence of hepatocellular carcinoma after liver retransplantation. Br Med J (Clin Res Ed) (1988) 0.75

Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio. BMC Cancer (2017) 0.75

Living donor liver transplantation for hepatocellular carcinoma achieves better outcomes. Hepatobiliary Surg Nutr (2016) 0.75

Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome. ISRN Hepatol (2014) 0.75

Liver transplantation for advanced hepatocellular carcinoma. Clin Mol Hepatol (2016) 0.75

Living donor liver transplantation for hepatocellular carcinoma in Seoul National University. Hepatobiliary Surg Nutr (2016) 0.75

[Long-term results of orthotopic liver transplantation during the cyclosporin era. 393 orthotopic liver transplantations accomplished in 313 consecutive patients at the Pittsburgh Transplantation Center]. Helv Chir Acta (1989) 0.75

Hepatocellular carcinoma. BMJ (1992) 0.75

Living donor liver transplantation for patients with hepatocellular carcinoma-20 years after introduction of the Milan criteria. Hepatobiliary Surg Nutr (2016) 0.75

Liver transplantation for hepatocellular carcinoma. Gut (1995) 0.75

Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats. Transplant Proc (1992) 0.75

Extended postinterventional tumor necrosis-implication for outcome in liver transplant patients with advanced HCC. PLoS One (2013) 0.75

Down-regulation of metabolic proteins in hepatocellular carcinoma with portal vein thrombosis. Clin Proteomics (2017) 0.75

Articles by these authors

Evolution of liver transplantation. Hepatology (1982) 19.54

A flexible procedure for multiple cadaveric organ procurement. Surg Gynecol Obstet (1984) 10.33

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Venous bypass in clinical liver transplantation. Ann Surg (1984) 7.04

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Vascular homografts from cadaveric organ donors. Surg Gynecol Obstet (1979) 6.23

Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. Surgery (1991) 5.92

Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Refinements in the surgical technique of liver transplantation. Semin Liver Dis (1985) 5.70

In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice. J Exp Med (1975) 5.53

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Alternative methods of arterialization of the hepatic graft. Surg Gynecol Obstet (1984) 5.16

Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03

Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01

Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc (1990) 4.90

Pancreaticoduodenal transplantation in humans. Surg Gynecol Obstet (1984) 4.49

Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology (1994) 4.32

A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. Surg Gynecol Obstet (1985) 4.29

Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21

Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18

Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery (1994) 4.16

Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg (1989) 4.12

Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Canine and human liver preservation for 6 to 18 hr by cold infusion. Transplantation (1977) 3.99

Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation (1985) 3.91

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73

Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66

Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64

Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63

Hepatic Retransplantation. Transplant Proc (1985) 3.62

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Combination donor hepatectomy and nephrectomy and early functional results of allografts. Surg Gynecol Obstet (1982) 3.49

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38

Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34

Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31

Early trials with FK 506 as primary treatment in liver transplantation. Transplant Proc (1990) 3.29

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26

The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24

Changes in blood coagulation. Arch Surg (1966) 3.22

Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. Surgery (1990) 3.18

Renal transplantation in baboons under FK 506. Surgery (1989) 3.17

Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation. Anesth Analg (1985) 3.17

Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen. Am J Pathol (1985) 3.16

Liver transplantation before 1 year of age. J Pediatr (1987) 3.15

In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15